We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 5,073 results
  1. Synchronous bilateral primary ovarian cancer with right endometroid carcinoma and left high-grade serous carcinoma: a case report and literature review

    Background

    Epithelial ovarian cancer is the most frequent gynecologic malignancy; it has a poor prognosis and often occurs bilaterally. Most cases of...

    Mimori Fujimori, Toshifumi Takahashi, ... Kazuyuki Takeichi in BMC Women's Health
    Article Open access 05 April 2022
  2. Development of a dual energy CT based model to assess response to treatment in patients with high grade serous ovarian cancer: a pilot cohort study

    Background

    In patients with cancer, the current gold standard for assessing response to treatment involves measuring cancer lesions on computed...

    Zena Alizzi, Andrew Gogbashian, ... Marcia Hall in Cancer Imaging
    Article Open access 15 June 2023
  3. A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression

    Human epididymis protein-4 (HE4/ WFDC2 ) has been well-studied as an ovarian cancer clinical biomarker. To improve our understanding of its functional...

    Nicole E. James, Megan Gura, ... Jennifer R. Ribeiro in Medical Oncology
    Article 15 May 2022
  4. USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model

    Epithelial ovarian cancer is the most lethal gynecologic malignancy and one of the most common causes of cancer mortality among women worldwide....

    Juntae Kwon, Hyeongjwa Choi, ... Cecil Han in Oncogene
    Article Open access 16 February 2022
  5. Preoperative prediction of miliary changes in the small bowel mesentery in advanced high-grade serous ovarian cancer using MRI radiomics nomogram

    Purpose

    To develop and validate an MRI-based radiomics nomogram for the preoperative prediction of miliary changes in the small bowel mesentery...

    Qinhao Guo, Zi**g Lin, ... Haiming Li in Abdominal Radiology
    Article 18 January 2023
  6. Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire

    Immunotherapeutic strategies aimed at enhancing tumor cell killing by tumor-specific T cells hold great potential for reducing tumor burden and...

    Douglas G. Millar, S. Y. Cindy Yang, ... Pamela S. Ohashi in Cancer Immunology, Immunotherapy
    Article Open access 21 March 2023
  7. AMIGO2 is involved in the spread of peritoneal metastasis in serous ovarian cancer via promoting adhesion to the peritoneal mesothelial cells

    Background

    Amphoterin-induced gene and open reading frame 2 (AMIGO2) have been reported to be related to the prognosis of colorectal, gastric, and...

    Yuki Iida, Mitsuhiko Osaki, ... Futoshi Okada in International Journal of Clinical Oncology
    Article 29 May 2024
  8. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer

    Background

    ETS transcription factors are known to act as either positive or negative regulators of the expression of genes involved in various...

    Lu Zhang, Ruiting Fu, ... Lin Tao in Journal of Ovarian Research
    Article Open access 04 November 2021
  9. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma

    Background

    High-grade serious ovarian carcinoma (HGSOC) is a subtype of ovarian cancer with a different prognosis attributable to genetic...

    Dandan Yuan, Hong Zhu, ... Yanjun Qu in European Journal of Medical Research
    Article Open access 27 October 2023
  10. Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram

    Objective

    This study aimed to explore the value of a radiomics nomogram to identify platinum resistance and predict the progression-free survival...

    Haiming Li, Songqi Cai, ... Zaiyi Liu in European Radiology
    Article 30 March 2023
  11. Intra- and peritumoral radiomics for predicting early recurrence in patients with high-grade serous ovarian cancer

    Purpose

    To explore values of intra- and peritumoral CT-based radiomics for predicting recurrence in high-grade serous ovarian cancer (HGSOC) patients.

    ...
    Yujiao Wu, Wenyan Jiang, ... **ngling Wang in Abdominal Radiology
    Article 29 November 2022
  12. Prognostic value of regulatory T cells and T helper 17 cells in high grade serous ovarian carcinoma

    Purpose

    In recent years the tumor microenvironment and its interaction with the tumor has emerged into research focus with increased attention to the...

    Sofya Marchenko, Iris Piwonski, ... Eliane Tabea Taube in Journal of Cancer Research and Clinical Oncology
    Article Open access 28 June 2022
  13. Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis

    Differential expression of programmed death-1 ligand (PD-L1) and its clinical significance in primary and metastatic ovarian high-grade serous...

    Tao Zhang, **n Zhou, ... Feng Zhou in Virchows Archiv
    Article 21 February 2023
  14. Rett Syndrome with Synchronous Serous Ovarian Borderline Tumor and Recurrent Villous Adenomas of Colon

    Introduction

    Rett syndrome is a rare neurodevelopmental disorder that is characterized by an early normal growth pattern followed by a progressive...

    Maria Kamal, Anoshia Afzal, Lewis Hassell in Indian Journal of Gynecologic Oncology
    Article 26 July 2023
  15. Targeted Therapies in Low-Grade Serous Ovarian Cancers

    Low grade serous carcinoma of the ovary has been delineated as a separate entity from its counterpart high grade serous carcinoma of the ovary....

    Anna Gonzalez, Christa I. Nagel, Paulina J. Haight in Current Treatment Options in Oncology
    Article Open access 13 June 2024
  16. Proteomic analysis of exosomes secreted during the epithelial-mesenchymal transition and potential biomarkers of mesenchymal high-grade serous ovarian carcinoma

    Background

    The epithelial-mesenchymal transition (EMT) promotes cell signaling and morphology alterations, contributing to cancer progression....

    Germano Aguiar Ferreira, Carolina Hassibe Thomé, ... Francisco José Candido dos Reis in Journal of Ovarian Research
    Article Open access 29 November 2023
  17. Metastasis of serous ovarian carcinoma to the breast: a case report and review of the literature

    Background

    Breast metastasis from primary ovarian cancer is rare, with an estimated frequency of 0.07%. More than 110 cases are reported in the...

    Sofia Dueño, Rachel Stein, ... Karina Hew in Journal of Medical Case Reports
    Article Open access 26 March 2024
  18. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine

    Purpose

    HGSOC is a kind of gynecological cancer with high mortality and strong heterogeneity. The study used multi-omics and multiple algorithms to...

    Daren Cai, Tiantian Liu, ... Yingbo Liu in Journal of Cancer Research and Clinical Oncology
    Article 13 May 2023
  19. An immune related signature inhibits the occurrence and development of serous ovarian cancer by affecting the abundance of dendritic cells

    Serous ovarian cancer is one of the major causes of cancer related death among women worldwide. The advanced diagnosis worsens the prognosis of...

    Fei Teng, Hong Wei, **aoqiu Dong in Discover Oncology
    Article Open access 15 June 2023
  20. Natural Killer Cells: the Missing Link in Effective Treatment for High-Grade Serous Ovarian Carcinoma

    Ovarian cancer (OC), especially high-grade serous cancer (HGSC), is a highly heterogeneous malignancy with limited options for curative treatment and...

    Morgan Pugh-Toole, Anna P. Nicolela, ... Jeanette E. Boudreau in Current Treatment Options in Oncology
    Article 22 February 2022
Did you find what you were looking for? Share feedback.